Anzahl der Publikationen: 10
Zeitschriftenartikel
Pozios, Ioannis; Hering, Nina A.; Günzler, Emily; Arndt, Marco; Elezkurtaj, Sefer; Knosel, Thomas; Bruns, Christiane J.; Margonis, Georgios A.; Beyer, Katharina und Seeliger, Hendrik
(2022):
Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 1: S. 271-280
Kamphues, Carsten; Lefevre, Jeremie H.; Wang, Jane; Amini, Neda; Beaugerie, Laurent; Kühn, Florian; Park, Sang Hyoung; Andreatos, Nikolaos; Lauscher, Johannes C.; Enea, Diana; Lehmann, Kai S.; Peru, Nicolas; Weixler, Benjamin; Kirchgesner, Julien; Degro, Claudius E.; Pozios, Ioannis; Beekum, Cornelius J. van; Schoelch, Sebastian; Zambonin, Daniela; Schineis, Christian; Loch, Florian N.; Geka, Despoina; Theoxari, Maria; Wu, Bin; Wang, Pei-Pei; Antoniou, Efstathios; Pikoulis, Emmanouil; Moussata, Driffa; Theodoropoulos, George; Ouaissi, Mehdi; Seeliger, Hendrik; Inaba, Yosuke; Scaringi, Stefano; Reissfelder, Christoph; Vilz, Tim O.; Lin, Chen; Yang, Suk-Kyun; Beyer, Katharina; Renz, Bernhard W.; Sasaki, Kazunari; Margonis, Georgios Antonios; Svrcek, Magali und Kreis, Martin E.
(2022):
Prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC-Is it the exception to the rule?
In: Surgical Oncology, Bd. 45, 101874
Lee, Lucas D.; Pozios, Ioannis; Liu, Verena; Nachbichler, Silke B.; Böhmer, Dirk; Kamphues, Carsten; Beyer, Katharina; Bruns, Christiane J.; Kreis, Martin E. und Seeliger, Hendrik
(2022):
Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma.
In: Radiation and Environmental Biophysics, Bd. 61, Nr. 2: S. 255-262
Pozios, Ioannis; Seel, Nina N.; Hering, Nina A.; Hartmann, Lisa; Liu, Verena; Camaj, Peter; Müller, Mario H.; Lee, Lucas D.; Bruns, Christiane J.; Kreis, Martin E. und Seeliger, Hendrik
(2020):
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ER beta and IL-6/gp130/STAT3 signaling.
In: Cellular Oncology, Bd. 44, Nr. 1: S. 167-177
Pozios, Ioannis; Knoesel, Thomas; Zhao, Yue; Assmann, Gerald; Pozios, Iraklis; Müller, Mario H.; Bruns, Christiane J.; Kreis, Martin E. und Seeliger, Hendrik
(2018):
Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.
In: Journal of Cancer Research and Clinical Oncology, Bd. 144, Nr. 10: S. 1887-1897
Zhao, Yue; Altendorf-Hofmann, Annelore; Pozios, Ioannis; Camaj, Peter; Däberitz, Therese; Wang, Xiaoyan; Niess, Hanno; Seeliger, Hendrik; Popp, Felix; Betzler, Christopher; Settmacher, Utz; Jauch, Karl-Walter; Bruns, Christiane und Knösel, Thomas
(2017):
Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma.
In: Journal of Cancer Research and Clinical Oncology, Bd. 143, Nr. 6: S. 1061-1068
Gallmeier, Eike; Bader, Dominik C.; Kriegl, Lydia; Berezowska, Sabina; Seeliger, Hendrik; Göke, Burkhard; Kirchner, Thomas; Bruns, Christiane und De Toni, Enrico N.
(2013):
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.
In: PLOS ONE
8(2), e56760
[PDF, 785kB]
Camaj, Peter; Seeliger, Hendrik; Ischenko, Ivan; Krebs, Stefan; Blum, Helmut; De Toni, Enrico N.; Faktorova, Dagmar; Jauch, Karl-Walter und Bruns, Christiane J.
(2009):
EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells.
In: Biological Chemistry, Bd. 390, Nr. 12: S. 1293-1302
[PDF, 218kB]
Diese Liste wurde am
Sat Dec 21 18:23:09 2024 CET
erstellt.